Novel human single chain antibody design based on the functional epitope of TNF
Hong CHANG,Ming Lü,Chun-xia QIAO,Xin-ying LI,Jing GENG,Ting-ting ZHOU,Zhou LIN,Bei-fen SHEN,Jian-nan FENG
DOI: https://doi.org/10.3969/cmba.j.issn.1673-713X.2014.04.001
2014-01-01
Abstract:Objective Developed novel human single chain antibody which design based on the functional epitope of TNF. Methods In a previous study, we obtained a TNF-α neutralizing mAb Z12 and identified the epitope (i.e. from 141 to 146 aa in TNF-α) recognized by Z12. Moreover, we explored a series of TNF-α antagonist peptides (i.e. PT2, PT3, PT4 and PT7) and the single domain antibody PTVH5 (using human antibody frame work of variable region of heavy chain, i.e. VH5, as scaffold to display the peptides PT2, PT3 and PT4) based on the interaction between TNF-α and mAb Z12. In the present work, based on the computer-guide molecular design, homology modeling and molecular docking method, we used human antibody frame work of variable region of light chain (Vκ1) as dispalying scaffold and obtained a novel single chain antibody, named as ScFv_AB1, according to the conformation, binding energy and identified domain. Results Theoretical analysis showed that ScFv_AB1 was stable and recognized the position 141-146 of TNF-α (same as Z12). Biological experiments showed that ScFv_AB1 could bind to TNF-α, competitively inhibit the binding of mAb Z12 to TNF-α, block the binding of TNF-αto TNFR and inhibit TNF-induced cytotoxicity. Conclusion This study demonstrated that it is feasible to design novel single chain antibody based on human antibody consensus frameworks and antagonist peptides using computer-guided modeling method. It also provides an alternative way to obtain human small molecular antibody.